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SUMMARY – Primary oral malignant melanoma usually presents as a dark brown or black 
lesion. It is a rare malignancy, accounting for less than 1% of all melanomas and 1.6% of all head 
and neck malignancies, thus forming up to 0.5% of all oral malignancies in the world literature. In 
general, the prognosis of oral melanoma is poor and worse than that of cutaneous melanoma. Th e 
preferred treatment is radical surgery alone or in combination with radiotherapy, chemotherapy, 
immunotherapy and immunomodulatory agents. A case is presented of a large malignant melanoma 
of oral cavity, noticed six months before initial biopsy and by history described as a rapidly growing 
mass.
Key words: Mouth neoplasms – diagnosis; Mouth neoplasms – pathology; Mouth neoplasma – surgery; 
Melanoma – diagnosis; Melanoma – pathology; Melanoma – surgery
Introduction
Melanomas of oral mucosa are fortunately rare. 
Primary oral malignant melanoma (POM) usually 
presents as a dark brown or black lesion, however, 15% 
of POMs are non-pigmented and typically red lesions, 
thus presenting as amelanotic melanomas that mimic 
some other oral mucosa red lesions1-5. Because of their 
rare occurrence, malignancies of this type are poorly 
documented in the literature. Most information on its 
clinical, epidemiologic and histopathologic features 
comes from small series of cases describing deep ex-
tension with or without bone invasion. Although there 
is no racial predilection, Afro-Americans and Asians 
appear to be proportionately more commonly aff ect-
ed than Caucasians4,6. Th e development of POM in 
relatively obscure areas of the oral cavity is the reason 
why it is diagnosed in a late stage at this location. Th e 
majority of POM cases develop on the head and neck 
mucosal surfaces (55%). It is a rare malignancy, ac-
counting for less than 1% of all melanomas and 1.6% 
of all head and neck malignances, thus forming up to 
0.5% of all oral malignancies in the world literature1-4. 
Approximately half of them are located in the oral 
cavity, placed on the palate and maxillary gingiva as 
the most frequently aff ected sites, with maxillary arch 
being aff ected in 80% of cases2,4,6. Dental clinicians 
play a major role in the identifi cation of pigmented 
lesions of oral cavity4. Th erefore, any pigmented lesion 
detected in the oral cavity that may exhibit poten-
tial growth should be submitted to biopsy to exclude 
malignancy1,4. In 2005, the incidence of gingival, soft 
palate and oropharyngeal POM in the Croatian pop-
ulation was 0.5, 0.3 and 1.1 per 100 000, respectively5. 
Th is malignancy is a lesion of adulthood, rarely oc-
curring under the age of 20 years, with the peak in-
cidence between 40 and 60 years of age2,4,7-9. POMs 
more commonly aff ect male patients, with a male to 
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female ratio ranging between 1:1 and 3:1 in diff erent 
studies2,4,7-10. 
Case Report
A 51-year-old male Caucasian was admitted to 
the hospital because of a painful mass on the left side 
of oral cavity. Th e patient noticed the growing mass 
some six months before presentation. Intraoral physi-
cal examination revealed an elevated, nodular, grey 
and slightly dark pigmented, erosive lesion of irregular 
borders, measuring up to 10 cm in diameter. Th e tu-
mor was located on the left side of the tongue infi ltrat-
ing the left tonsil, hard and soft palate and left maxil-
lary canine region, extending through oral cavity to 
its right side and to the oropharynx (Fig. 1). Incisional 
biopsy was performed. Histopathologic hematoxylin-
eosin stained biopsy sections showed oral stratifi ed 
squamous epithelium with a malignant neoplasm. It 
comprised of sheets and fascicles of atypical, heavily 
pigmented melanocytes spindle or ovoid in shape. Th e 
malignant melanocytes had hyperchromatic polymor-
phic nuclei and high nucleocytoplasmic ratio exhib-
iting numerous mitoses (Fig. 2). We used antibodies 
for routine diagnosis of melanoma (HMB-45), which 
produced intensive staining of tumor cells (Fig. 3), 
and in addition Melan-A, vimentin and Ki-67 (pho-
tograph is not available due to the very small size of 
the specimen and thus poor reaction). On diff erential 
diagnosis, we used keratin and epithelial membrane 
antigen (EMA), which showed no expression on tu-
mor cells, thus confi rming the melanocytic nature of 
the lesion. Th e lesion was diagnosed pathologically 
as oral melanoma. Th e tumor extended deep into the 
connective tissue but not in the underlying bone. Sur-
gical treatment was not possible because of the large 
size of the tumor. Radiotherapy by Mavathron for 
three weeks on two reverse fi elds with 6 mega electron 
volts was initiated two months of the initial biopsy. 
Nuclear magnetic resonance (NMR) performed one 
Fig. 1. Physical examination revealed a large, dark, 
nodular, proliferative tumor growth on the left side of the 
tongue, infi ltrating the left tonsil, hard and soft palate, 
and maxillary canine region. 
Fig. 2. Photomicrograph showing infi ltration with numer-
ous atypical pleomorphic melanocytes containing brownish-
black granular pigment in the cytoplasm (H&E, X400); 
Fig. 3. Tumor showing intense HMB-45 positive reaction 
in malignant melanocytes (X400).
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month after radiotherapy showed that there was no 
invasion of thoracic and abdominal lymph nodes and 
organs. Follow up examination at six months revealed 
partial regression of the tumor on the hard palate and 
left buccal mucosa. Isthmus faucium was completely 
obstructed by the round tumor mass measuring up to 
6 cm in diameter. Th e submandibular area revealed 
conglomerates of lymph nodes measuring up to 7x4 
cm bilaterally. Subjectively, the patient denied pain 
in the oral cavity. Eight months later, the patient was 
still on therapy. Ten months after the fi rst diagnosis, 
he was hospitalized, accepting only pain killers and 
refused the immunotherapy proposed. Ten months 
later, the patient died. Th e exact cause of death was 
not established because autopsy was not performed.
Discussion
Oral cavity is a common site of various brown 
or black pigmented lesions, e.g., amalgam tattoo, 
pigmented nevi, Addison’s disease, Peutz-Jeghers 
syndrome, racial pigmentation melanotic macules 
associated with HIV infection, smoker melanosis, 
drug-induced pigmentation and melanoma1,4. Most 
pigmented lesion are benign, but despite the rarity of 
the disease, POM is the most important pigmented 
lesion in the oral cavity because of its deadly nature 
and must be diagnosed in time. Most if not all oral 
biopsies of pigmented lesions are aimed at excluding 
malignant melanoma1,4,11. If diagnosed early, when 
the malignant cells are limited to the epidermis or 
the invasion is minimal, cutaneous melanoma is ei-
ther 100% curable by excision or is associated with a 
5-year survival rate of 95% versus 45% for a similar 
melanoma thicker than 4 mm1,12-16. Th e prognosis of 
POM is much worse, with 5-year survival rates gener-
ally ranging from 10% to 25%, or according to some 
authors 15%-38%, partly because of diffi  culties to de-
tect pigmented lesion and poor resectability due to the 
anatomy of the region, major extension in depth versus 
cutaneous melanoma, and early metastasis1,8. Th e me-
dian survival for all POMs is slightly over 2 years (18-
46 months) from the time of diagnosis, depending on 
lymph node involvement, increased tumor thickness, 
and level and vertical growth phase of the tumor at 
the diagnosis8,16-21. POM is an uncommon malignant 
tumor that originates from melanocyte proliferation. 
During embryologic development, melanocytes mi-
grate from neural crest into the epithelial lining of the 
skin. As the oral cavity develops from an ectodermal 
depression or invagination, the epithelial lining of 
oral mucosa, similar to the skin, contains melanocytes 
in its basal layer1,2,4. Some authors suggest that there 
are more than one biologic type of oral melanoma, i.e. 
invasive (without signifi cant lateral spread) and in situ 
subtype undergoing a junctional growth phase that 
may last for months to years before entering the ver-
tical growth phase4. A third term, atypical melano-
cytic proliferation, has been used in relation to diffi  -
cult macroscopic detection of oral pigmentation when 
the presence of unusual numbers of melanocytes with 
abnormal morphology at the epithelium-connective 
tissue interface is detected4,20,21. POM is usually as-
ymptomatic in the early stages, presenting as a pig-
mented patch or rarely as a mass with a rapid grow 
rate. We report a case where the patient’s underesti-
mation of his symptoms, probably due to its painless 
character, was the main reason for not seeking medi-
cal care in time. He presented in an advanced stage of 
the disease. Generally, the lesion can be fl at (macula) 
or elevated (nodule or exophytic), with or without ul-
ceration or erythematous border1-4. In the advanced 
stage, it can show ulceration, swelling, bleeding, rapid 
enlargement and tooth loosening1,2,11. Clinically, tu-
mors are classifi ed in fi ve types: 1) pigmented nodu-
lar; 2) non-pigmented nodular; 3) pigmented macular; 
4) pigmented mixed; and 5) non-pigmented mixed 
type1,2. Approximately half of POMs in the oral cav-
ity are located on the palate and maxillary gingiva as 
the most frequently aff ected sites2,4,16,17. In contrast to 
the well established etiologic factors for skin mela-
noma, the causative factors of POM such as family 
history, syndromes, and cytogenetic defects have not 
been studied extensively2,10. Th e International Union 
against Cancer (UICC) and the American Joint 
Committee on Cancer (AJCC) and World Health 
Organization (WHO) have not yet proposed clini-
cal TNM classifi cation for malignant melanomas and 
guidelines for POM staging either16,18,21-24. Th e Clark 
grading system assessing the depth of invasion and 
Breslow measuring the thickness of the tumor from 
the surface of the epidermis to the greatest depth of 
the tumor have no validation as prognostic factors in 
POMs due to the rarity of this lesion. In 2004, some 
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authors proposed a clinical staging system with his-
topathologic microstaging in three levels for stage I 
(with no regional lymph node metastases), cited in 
several review articles10,12,21,22,25. Th e common sites 
of metastases are lymph nodes, liver and lungs, with 
wide dissemination in the advanced disease12,14,26,27. 
Surgery is the mainstay of treatment, but it is often 
diffi  cult to perform because of the anatomic region 
features. Although melanoma is classically not very 
radiosensitive, patients have occasionally had good re-
sponse to radiotherapy, especially in melanoma in situ 
and in cases with very poor prognosis when surgery is 
rejected. Adjuvant radiotherapy to the primary loca-
tion, immunotherapy (interferon alpha-2b) and che-
motherapy (dacarbazine-DTIC), along with immu-
nomodulatory agents such as bacilli Calmette-Guérin 
(BCG) and recombinant interleukin-2 (rIL-2), may be 
combined with surgery3,13-18,20. Th e prognosis of mela-
noma is poor, with a mean 5-year survival after resec-
tion of 5% to 38%, 26% when the lesion was confi ned 
to the primary site, and declining to 0% in the pres-
ence of regional lymph node or distant metastases. Th e 
importance of this malignancy lies in its high aggres-
siveness, with a 5-year survival rate ranging from 10% 
to 25% in the literature1-4,17-19. Inadequate resection of 
the margins and a higher stage at initial diagnosis may 
contribute to this poor rate of survival18.
Although the prognosis of oral melanoma is gen-
erally poor, the early identifi cation and initial biopsy 
of pigmented oral lesion should be done to exclude 
the presence of oral melanoma. Patient’s compli-
ance is of utmost importance in detecting oral pig-
mented lesions, along with appropriate physician’s 
and dentist’s diagnostic skills supported by histology 
confi rmation1,2,10,24,28,29. Early diagnosis of oral mela-
noma is more important for successful treatment than 
at any other primary site and is one of the key fac-
tors for better prognosis; unfortunately, it remains un-
proven because of the small number of cases. In case 
of high clinician’s suspicion, repeat biopsies should be 
performed irrespective of the possibly benign features 
shown on initial biopsy. Analysis of published cases 
and recognition of new ones may be helpful in estab-
lishing defi nite classifi cation and proposing clinical 
features that would facilitate its early diagnosis as a 
prerequisite for timely treatment and better prognosis 
of this rare pathology30.
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Sažetak
PRIMARNI ZLOĆUDNI MELANOM SLUZNICE USNE ŠUPLJINE
T. Bujas, I. Pavić, A. Prus, Z. Marušić i D. Baličević
Primarni melanom sluznice usne šupljine obično je tamno smeđe ili crno pigmentirana lezija. Vrlo je rijetka zloćudna 
bolest koja se javlja u manje od 1% svih melanoma i čini 1,6% svih maligniteta glave i vrata tvoreći, kako navodi svjetska 
literatura, do 0,5% svih maligniteta u usnoj šupljini. Općenito, prognoza je lošija nego kod kožnih melanoma. Kirurška 
resekcija je jedan od najčešćih oblika liječenja, a pokušava se i radioterapijom, kemoterapijom, imunoterapijom i imunomo-
dulatorima. Opisuje se slučaj velikog melanoma u usnoj šupljini ubrzani rast kojega je primijećen šest mjeseci prije biopsije 
i potvrđene dijagnoze.
Ključne riječi: Novotvorine usne šupljine – dijagnostika; Novotvorine usne šupljine – patologija; Novotvorine usne šupljine – 
kirurgija; Melanom – dijagnostika; Melanom – patologija; Melanom – kirurgija
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